Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

coactiv+™ Antimicrobial Wound Gel

K-Number: K223259 · 2023-05-24

Decision Date2023-05-24
Product CodeFRO
DecisionSubstantially Equivalent

Device Summary

coactiv+™ Antimicrobial Wound Gel is a medical device manufactured by Kane Biotech, Inc.. It received FDA 510(k) clearance on 2023-05-24 under approval number K223259. The device is classified under product code FRO. Product code FRO falls under the category of Anesthesiology, which includes devices for anesthetic delivery and patient monitoring. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the coactiv+™ Antimicrobial Wound Gel?

coactiv+™ Antimicrobial Wound Gel is a medical device that received FDA 510(k) clearance on 2023-05-24. It is manufactured by Kane Biotech, Inc.. The 510(k) number is K223259.

When was coactiv+™ Antimicrobial Wound Gel approved by the FDA?

coactiv+™ Antimicrobial Wound Gel received FDA 510(k) clearance on 2023-05-24, under approval number K223259.

What company makes coactiv+™ Antimicrobial Wound Gel?

coactiv+™ Antimicrobial Wound Gel is manufactured by Kane Biotech, Inc..

What is the FDA product code for coactiv+™ Antimicrobial Wound Gel?

The FDA product code for coactiv+™ Antimicrobial Wound Gel is FRO. This falls under the Anesthesiology category.

Related Clinical Trials

Related PubMed Literature

Other Devices by Kane Biotech, Inc.

Related Devices (Code: FRO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.